Intersect ENT, Inc. — key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$106.7M

Net Income/Loss (FY2021)

-$159.6M

Total Assets (FY2021)

$146.9M

Total Equity (FY2021)

-$69.1M

Cash Flows from Operating Activities (FY2021)

-$59.5M

Source: Intersect ENT, Inc. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.